By: brianprimack
Day: May 14, 2012
Malpractice Trends: Good News and Bad News
Results from an analysis of more than 10,000 medical malpractice claims show that more than half resulted in litigation, with outcomes varying considerably by specialty. Medscape Medical News
Retrospective study: Topical antibiotics increase risk of endophthalmitis after intravitreal injections
Source: Ophthalmology
Area: News
This retrospective Canadian study examined the incidence of endophthalmitis (inflammatory condition of the intraocular cavities) following different antibiotic prophylaxis strategies for intravitreal injections of anti…
Changes in Eye Vessels Signal Heart Troubles (CME/CE)
(MedPage Today) — Changes in diameter of the tiny blood vessels in the retina predicted the later development cardiovascular disease in African-Americans with type 1 diabetes, researchers found.
Five-point checklist to protect eyes from sun’s harmful rays
Like your skin, overexposure to the sun can wreak havoc on your eyes. Sun damage can cause severe conditions such as sunburn to the cornea, tissue growth on the surface of eyes that can block vision, skin cancer of the eyelids and may even contribute t…
Vision Loss Due To Degenerative Eye Diseases May Be Restored By New Type Of Retinal Prosthesis
Using tiny solar-panel-like cells surgically placed underneath the retina, scientists at the Stanford University School of Medicine have devised a system that may someday restore sight to people who have lost vision because of certain types of degenera…
New system may help restore vision in eye diseases
Using tiny solar-panel-like cells surgically placed underneath the retina, scientists at the Stanford University School of Medicine have devised a system that may someday restore sight to people who have lost vision because of certain types of degenera…
VEGF Trap-Eye improves vision in diabetic eye disease
NEW YORK (Reuters Health) -Vascular Endothelial Growth Factor (VEGF) Trap-Eye provided a significant
benefit to patients with diabetic macular edema in a phase II trial – and updated data now shows the initial
improvements were sustained or inc…